Fanhua blueplus forming strategic partnerships with shanghai biotecan pharmaceuticals

Guangzhou, china, sept. 06, 2024 (globe newswire) -- fanhua inc. (nasdaq: fanh) (the “company” or “fanhua”), a leading independent technology-driven financial services provider in china, today announced that it, through its wholly-owned subsidiary fanhua blueplus health management co., ltd. (“fanhua blueplus”) has recently signed a strategic cooperation agreement with shanghai biotecan pharmaceuticals co. ltd. (“biotecan”).
FANH Ratings Summary
FANH Quant Ranking